Nan Shan Life Insurance’s Thermo Fisher Scientific TMO Stock Holding History

Nan Shan Life Insurance’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,686	Closed	-$1.3M	–	97
2025 Q3	$1.3M	Hold	2,686	–	–	0.03%	100
2025 Q2	$1.09M	Sell	2,686 -2	-0.1%	-$836	0.02%	111
2025 Q1	$1.34M	Hold	2,688	–	–	0.03%	103
2024 Q4	$1.4M	Sell	2,688 -50,634	-95%	-$27.8M	0.03%	103
2024 Q3	$33M	Sell	53,322 -23,000	-30%	-$13.6M	0.78%	44
2024 Q2	$42.2M	Buy	76,322 +5,000	+7%	+$2.86M	1%	38
2024 Q1	$41.5M	Hold	71,322	–	–	0.98%	37
2023 Q4	$37.9M	Hold	71,322	–	–	0.92%	39
2023 Q3	$36.1M	Buy	71,322 +18,000	+34%	+$9.59M	0.98%	40
2023 Q2	$27.8M	Buy	53,322 +3,883	+8%	+$2.1M	0.67%	51
2023 Q1	$28.5M	Buy	49,439 +42,090	+573%	+$23.7M	0.68%	50
2022 Q4	$4.05M	Hold	7,349	–	–	0.11%	82
2022 Q3	$3.73M	Sell	7,349 -66,235	-90%	-$37.1M	0.09%	86
2022 Q2	$40M	Hold	73,584	–	–	0.84%	40
2022 Q1	$43.5M	Hold	73,584	–	–	0.76%	41
2021 Q4	$49.1M	Hold	73,584	–	–	0.74%	48
2021 Q3	$42M	Hold	73,584	–	–	0.7%	47
2021 Q2	$37.1M	Buy	73,584 +60,454	+460%	+$28.5M	0.63%	61
2021 Q1	$5.99M	Sell	13,130 -42,412	-76%	-$20.2M	0.12%	105
2020 Q4	$25.9M	Buy	+55,542	New	+$26M	0.53%	60

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Nan Shan Life Insurance's TMO Position: Q4 2025 in Review

Nan Shan Life Insurance sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 2,686 shares — an estimated $1.3M sold.

Nan Shan Life Insurance first reported a position in TMO in Q4 2020 and held it in 20 quarters. The position peaked at $49.1M in Q4 2021. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Nan Shan Life Insurance reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
Nan Shan Life Insurance sold 2,686 Thermo Fisher Scientific shares in Q4 2025, an estimated $1.3M.
Nan Shan Life Insurance first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 20 quarters.
Nan Shan Life Insurance's Thermo Fisher Scientific position peaked at $49.1M in Q4 2021.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Nan Shan Life Insurance's 13F filing for Q4 2025, filed 13 Feb 2026.